ArticleNature communications2022

S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy.

Jianjie Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.